Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.


    In Memory of Sebastian

    Sebastien passed away July 14, 2020 from dedifferentiated chondrosarcoma. This narrative was written and submitted by his sister Stephanie Desjardins. In April 2019, my brother was diagnosed with a chondrosarcoma of chest wall on the right side…

    Read Article

    Memorial Sloan Kettering Information Session: Empowering Patients: Speak Up For Your Health

    Empowering Patients: Speak Up For Your Health Tuesday, May 11, 2021 at 12:00 PM ET Please consider registering to a special information session where our panel of experts will discuss the importance of advocating for patient care and treatment….

    Read Article

    Bone Cancer Research Trust Hosts Webinar on Anxiety and Fear of Recurrence

    The Bone Cancer Research Trust is hosting a free Support & Information Webinar. It features Carol Hughes who will provide a presentation on Managing the fear of recurrence, On Thursday 29th April We know that when treatment for primary bone…

    Read Article

    Proton therapy induces biologic response to attack treatment-resistant cancers

    Proton therapy induces biologic response to attack treatment-resistant cancers February 17, 2021 ROCHESTER, Minn. — Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist…

    Read Article

    Cancer May Be Driven by DNA Outside of Chromosomes

    In the last decade, researchers have come to realize that tumors harbor bits of extrachromosomal DNA that can drive malignancy. Paul Mischel Apr 1, 2021 338 In the spring of 2012, my colleagues and I began to notice something strange in tumor…

    Read Article

    A Pilot Study of Lenvatinib Plus Pembrolizumab Immunotherapy in Patients with Advanced Sarcoma

    The purpose of this study is to learn whether combining lenvatinib and pembrolizumab is a safe and effective treatment for patients with metastatic soft tissue sarcomas that cannot be surgically removed. This study will include patients with…

    Read Article


    A team of researchers say they’ve designed a personalized cancer vaccine capable of inducing an immune response that fights off melanoma, the deadliest form of skin cancer, that lasts for several years. In a study published in the journal Nature…

    Read Article

    Help Get The Word Out and the Virtual Dialogue Videos

    It’s Spring, Passover is ending, it’s Easter Sunday….. their is a light at the end of the dark tunnel of the pandemic and hope for a new beginning. With the knowledge of new medications and technologies for early diagnosis of Chondrosarcoma, my…

    Read Article

    Contact Information

    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message